Since Pseudomonas aeruginosa is capable of biosynthesis of polyhydroxyalkanoic acid (PHA) and rhamnolipids, which contain lipid moieties that are derived from fatty acid biosynthesis, we investigated various fab mutants from P. aeruginosa with respect to biosynthesis of PHAs and rhamnolipids. All isogenic fabA, fabB, fabI, rhlG, and phaG mutants from P. aeruginosa showed decreased PHA accumulation and rhamnolipid production. In the phaG (encoding transacylase) mutant rhamnolipid production was only slightly decreased. Expression of phaG from Pseudomonas putida and expression of the ␤-ketoacyl reductase gene rhlG from P. aeruginosa in these mutants indicated that PhaG catalyzes diversion of intermediates of fatty acid de novo biosynthesis towards PHA biosynthesis, whereas RhlG catalyzes diversion towards rhamnolipid biosynthesis. These data suggested that both biosynthesis pathways are competitive. In order to investigate whether PhaG is the only linking enzyme between fatty acid de novo biosynthesis and PHA biosynthesis, we generated five Tn5 mutants of P. putida strongly impaired in PHA production from gluconate. All mutants were complemented by the phaG gene from P. putida, indicating that the transacylase-mediated PHA biosynthesis route represents the only metabolic link between fatty acid de novo biosynthesis and PHA biosynthesis in this bacterium. The transacylase-mediated PHA biosynthesis route from gluconate was established in recombinant E. coli, coexpressing the class II PHA synthase gene phaC1 together with the phaG gene from P. putida, only when fatty acid de novo biosynthesis was partially inhibited by triclosan. The accumulated PHA contributed to 2 to 3% of cellular dry weight.
A wide variety of microorganisms accumulate polyhydroxyalkanoic acids (PHAs), mostly polyhydroxybutyrate, as metabolic storage materials, which are deposited as intracellular water-insoluble inclusions (1, 22) . Meanwhile, more than 150 constituents of PHAs have been found (38) . Recently, it was shown that provision of 3-mercaptopropionic acid as a carbon source resulted in biosynthesis of a novel sulfur-containing polyester with thioester linkages by Ralstonia eutropha (21) . Most fluorescent pseudomonads belonging to rRNA homology group I, e.g., Pseudomonas aeruginosa and Pseudomonas putida, are able to synthesize and accumulate large amounts of PHAs consisting of various 3-hydroxy fatty acids with carbon chain lengths ranging from 6 to 14 carbon atoms (medium chain length [MCL] PHAs [PHA MCL ]) as carbon and energy storage compounds from cheap carbon sources, e.g., low-rank coal liquefaction products or waste oil from biotechnological rhamnose production (1, 9, 10, 22, 39, 40) . The composition of PHA depends on the PHA synthases, the carbon source, and the metabolic routes involved (29, 31, 32) . ␤-Oxidation is the main pathway when fatty acids are used as a carbon source, and fatty acid de novo biosynthesis is the main route during growth on carbon sources which are metabolized to acetyl coenzyme A (acetyl-CoA), like gluconate, acetate, or ethanol (16, 28, 32) . Recently, recombinant PHA MCL synthesis was also obtained in ␤-oxidation mutants of Escherichia coli LS1298 (fadB) or RS3097 (fadR) expressing PHA synthase genes from P. aeruginosa (20, 24, 25) , indicating that the ␤-oxidation pathway in E. coli provides precursors for PHA synthesis. It has also been recently shown that coexpression of the thioesterase genes with a PHA synthase gene in E. coli fad mutants causes synthesis of PHA MCL from the carbon source gluconate (18, 30) . These data suggested that the fatty acid de novo synthesis as well as the ␤-oxidation pathways were involved. It was recently confirmed that the purified PHA MCL synthases from P. aeruginosa exhibit in vitro enzyme activity with (R)-3-hydroxydecanoyl-CoA as the substrate (26) . Thus, to serve as a substrate for the PHA synthase, (R)-3-hydroxyacyl-acyl carrier protein [(R)-3-hydroxyacyl-ACP], which is an intermediate of fatty acid de novo synthesis, must be converted to the corresponding CoA-derivative. Recently, the transacylase PhaG Pp from P. putida, which catalyzes the transfer of the (R)-3-hydroxydecanoyl moiety from the ACP thioester to CoA, has been identified and characterized (28) . Thus, PhaG directly links fatty acid de novo biosynthesis with PHA biosynthesis (Fig. 1) . Meanwhile, phaG genes were isolated and characterized from Pseudomonas oleovorans and P. aeruginosa and evidence was obtained that this transacylase-mediated pathway is widespread among pseudomonads (14, 15) . Interestingly, in P. aeruginosa about 40% of the accumulated PHA is provided via alternative pathways from gluconate as the carbon source independent of the transacylase PhaG (14) . In non-PHA-accumulating Pseudomonas fragi the coexpression of phaG Pp with phaC1 Pa established a new pathway for PHA MCL biosynthesis from fatty acid de novo biosynthesis using nonrelated carbon sources, e.g., gluconate or acetate (8) .
P. aeruginosa is capable of producing various exoproducts, such as exoenzymes, pyocyanine, the exopolysaccharide alginate, and rhamnolipids. Rhamnolipids are glycolipids, which reduce water surface tension and emulsify oil. These rhamnolipids produced by P. aeruginosa in liquid cultures are mainly rhamnosyl-␤-hydroxydecanoyl-␤-hydroxydecanoate (monorhamnolipid) and rhamnosyl-rhamnosyl-␤-hydroxydecanoyl-␤-hydroxydecanoate (dirhamnolipids). Rhamnolipid biosynthesis proceeds through transfer of two rhamnose moieties from TDP-L-rhamnose (3) . For the synthesis of monorhamnolipid, the enzyme rhamnosyltransferase 1 (Rt 1) catalyzes the rhamnose transfer to ␤-hydroxydecanoyl-␤-hydroxydecanoate, while Rt 2 synthesizes dirhamnolipid from TDP-L-rhamnose and monorhamnolipid. Genes coding for biosynthesis, regulation, and induction of the Rt 1 enzyme are organized in tandem in the rhlABRI gene cluster (23) . The gene rhlC, which encodes the Rt 2 enzyme, has been very recently described (27) . This enzyme is homologous to rhamnosyltransferases involved in lipopolysaccharide biosynthesis. Recently, Campos-Garcia et al. (4) identified the rhlG gene encoding a ␤-ketoacyl reductase, which is presumably involved in the biosynthesis of rhamnolipids. RhlG is supposed to catalyze the NADPH-dependent reduction of ␤-ketodecanoyl-ACP, which is an intermediate of fatty acid de novo biosynthesis, resulting in ␤-hydroxydecanoyl-ACP, a putative precursor for rhamnolipid biosynthesis (Fig. 1) .
Since both PHA and rhamnolipid contain lipid moieties which are derived from fatty acid biosynthesis, we investigated various fab mutants from P. aeruginosa with respect to the biosynthesis of PHA and rhamnolipid. Furthermore, the influ- ence of the transacylase PhaG and the ␤-ketoacyl reductase RhlG on the synthesis of PHA and rhamnolipid, respectively, was studied. Moreover, we generated Tn5 mutants of P. putida deficient in PHA MCL biosynthesis from gluconate in order to investigate whether other genes are required for this specific pathway. Finally, the transacylase-mediated pathway for PHA-MCL synthesis from gluconate was established in recombinant E. coli.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth of bacteria. Pseudomonads and E. coli strains as well as the plasmids used in this study are listed in Table 1 . E. coli was grown at 37°C in complex Luria-Bertani (LB) medium. Pseudomonads were grown at 30°C in 300-ml baffled flasks containing 50 ml of either LB medium, PPGAS medium (NH 4 (34) , and if required antibiotics were added to appropriate concentrations. The amounts of antibiotics used for P. aeruginosa were as follows (per milliliter): 300 g of carbenicillin, 250 g of gentamicin, 150 g of tetracycline, and 300 g of kanamycin. The amounts of antibiotics used for P. putida were as follows (per milliliter): 10 g of gentamicin and 50 g of kanamycin. The amounts of antibiotics used for E. coli were as follows (per milliliter): 50 g of kanamycin and 100 g of ampicillin.
Isolation, analysis, and manipulation of DNA. DNA sequences of new plasmid constructs were confirmed by DNA sequencing according to the chain termination method using the model 4000L automatic sequencer LI-COR (MWGBiotech, Ebersberg, Germany). All other genetic techniques were performed as described by Sambrook et al. (33) .
Tn5 mutagenesis.
In order to generate mutants of P. putida, which are defective in PHA MCL biosynthesis from nonrelated carbon sources, such as gluconate, we performed Tn5 mutagenesis. The suicide plasmid pMON5302 (Monsanto, St. Louis, Mo.) was constructed by insertion of the Tn5 IS50L and IS50R regions comprising a gentamicin resistance cassette [AAC(3)-I gene] into plasmid pACYC (Monsanto). The plasmid was transferred into P. putida KT2440 by conjugation as previously described (27) , and Tn5 mutants were screened on MM agar plates containing 1.5% (wt/vol) gluconate as the sole carbon source. Colonies which appeared nonopaque were isolated, and after cultivation in the same medium the cells were analyzed with respect to PHA accumulation.
Plasmid construction. The coding region of the P. putida phaG Pp gene was amplified by tailored PCR using primers with noncomplementary 5Ј ends, introducing BamHI and XbaI restriction sites at either end of the PCR product by using plasmid pBHR75 as the template (28) . The coding region of the PHA synthase gene phaCl Pa from P. aeruginosa was amplified by tailored PCR using plasmid pBHR71 as the template (20), introducing the EcoRI restriction site and the ribosome binding site at the 5Ј end and the BamHI restriction site at the 3Ј end. The following oligonucleotides were applied for the PCRs: 5Ј-CCCGAAT TCAATAAGGAGATATACATATGAGTCAG-3Ј (5Ј end) and 5Ј-TGCTCTA GAGGGCCCCCCCTCGAGGTC-3Ј (3Ј end) (phaCl Pa ); and 5Ј-CGCGGATC CAAGGAGTCGATGACATG-3Ј (5Ј end) and 5Ј-GCGTCTAGACTACAAG GCGCCGAGCCG-3Ј (3Ј end) (phaG Pp ). Both PCR products were simultaneously subcloned into restriction sites EcoRI and XbaI of the vector pBBR1MCS-2, resulting in the insertion of the PHA synthase gene and the transacylase gene collinear to the lac promoter. The resulting plasmid, pBHR87, enabled functional coexpression of phaCl Pa and phaG Pp .
Functional expression of PHA MCL synthase gene. PHA synthase activity was confirmed by expression of the respective PHA synthase gene in various metabolic backgrounds favoring PHA MCL synthesis, e.g., E. coli RS3097 and P. putida GPp104 (25, 26) . Recombinant bacteria harboring the respective plasmid were cultivated in the presence of 0.25% (wt/vol) decanoate. PHA accumulation was (8, 14, 28) . Recombinant cells were cultivated in MM plus 1.5% (wt/vol) sodium gluconate, and after 48 h of incubation at 30°C the PHA content of lyophilized cells was determined by GC analysis. PHA accumulation from gluconate indicated in vivo activity of PhaG.
Functional expression of Rh1G (␤-ketoacyl reductase) gene. Functional expression of rhlG (encoding the ␤-ketoacyl reductase) based on pJC3 was confirmed by complementation of the rhlG mutant P. aeruginosa ACP5 (4). Recombinant cells were cultivated on PPGAS medium, and after 24 h of incubation at 37°C the rhamnolipid concentration in the cell supernatant was determined and indicated in vivo activity of ␤-ketoacyl reductase.
GC analysis of polyester and fatty acids in cells. PHAs and fatty acids were qualitatively and quantitatively analyzed by GC. Liquid cultures were centrifuged at 10,000 ϫ g for 15 min, and then the cells were washed twice in saline and lyophilized overnight. Lyophilized cell material (8 to 10 mg) was subjected to methanolysis in the presence of 15% (vol/vol) sulfuric acid. The resulting methyl esters of the constituent 3-hydroxyalkanoic acids were assayed by GC according to the method of Brandl et al. (2) and as described in detail recently (40) . GC analysis was performed by injecting 3 l of sample into a Perkin-Elmer (Ü berlingen, Germany) 8420 gas chromatograph using a 0.5-m-diameter Permphase PEG 25 Mx capillary column 60 m in length.
Analysis of rhamnolipids. The orcinol assay (5) was used to directly assess the amount of rhamnolipids in the sample: 333 l of the culture supernatant was extracted twice with 1 ml of diethyl ether. The ether fractions were pooled and evaporated to dryness, and 0.5 ml of H 2 O was added. To 100 l of each sample 900 l of a solution containing 0.19% orcinol (in 53% [vol/vol] H 2 SO 4 ) was added; after being heated for 30 min at 80°C, the samples were cooled for 15 min at room temperature, and the A 421 was measured. The concentration of rhamnolipids was calculated by comparing the data with those obtained with rhamnose standards between 0 and 50 g/ml.
RESULTS
Analysis of various isogenic P. aeruginosa mutants with respect to PHA and rhamnolipid synthesis. Since precursors for PHA and rhamnolipid biosynthesis are derived from fatty acid de novo biosynthesis, various fab mutants of P. aeruginosa were analyzed. For PHA biosynthesis analysis cells were cultivated under PHA-accumulating conditions on MM containing 1.5% (wt/vol) sodium gluconate, 0.01% (vol/vol) oleate, and 0.05% (wt/vol) ammonium chloride. For rhamnolipid biosynthesis analyses cells were cultivated in PPGAS medium containing 0.5% (wt/vol) glucose as the carbon source. The fabA mutant PAO191 carries a Gm r cassette in the fabA gene, which encodes ␤-hydroxyacyl-ACP dehydratase. The fabB mutant PAO192 was constructed by insertion of the Gm r cassette into the fabB gene, which encodes ␤-ketoacyl-ACP synthase I (12). Moreover, the isogenic fabI mutant PAO235 was employed, which carries an insertionally inactivated fabI gene that encodes enoyl-ACP reductase (13) . In addition to the various fab mutants, we used the isogenic phaG mutant KO2, which is impaired in PHA MCL accumulation from nonrelated carbon sources (14) , and the isogenic rhlG mutant ACP5, which is almost deficient of rhamnolipid production, i.e., it produced less than 1.3% of the rhamnolipid produced by the wild type (4). These mutants were studied with respect to their capability to produce PHA MCL and rhamnolipids. The fab mutants were strongly impaired in PHA MCL accumulation and rhamnolipid production, whereas the the phaG mutant showed only 40% of wild-type PHA MCL accumulation and only a slightly decreased rhamnolipid production ( Fig. 2 and 3) . The rhlG mutant showed a decreased PHA MCL accumulation and rhamnolipid production. Transfer of the phaG gene into the fab mutants showed a strong increase in PHA MCL accumulation, whereas rhamnolipid biosynthesis was almost abolished (Fig. 2 and 3 ). In the rhlG mutant PHA MCL accumulation was slightly decreased and no effect on rhamnolipid synthesis was observed when phaG was expressed ( Fig. 2 and 3) . Transfer of the rhlG gene into these mutants mediated an increase of rhamnolipid production in mutants ACP5 (complementation of mutation), KO2, and PA235, whereas PHA MCL accumulation was decreased in all mutants except in ACP5 ( Fig. 2 and 3) . In order to obtain evidence for the potential precursor of PHA MCL synthesis, the PHA MCL composition of all mutants was analyzed. GC analysis of the accumulated PHA showed that in the phaG knockout mutant KO2 the molar fraction of the 3-hydroxydecanoate (3HD) in PHA MCL was decreased by approximately 20%, whereas in the rhlG mutant ACP5 this molar fraction was slightly increased ( Table 2) . Generation of independent Tn5 mutants of P. putida deficient in PHA MCL accumulation. Since the transacylase PHA biosynthesis pathway was described in Pseudomonas, the only gene involved that has been identified so far is phaG, capable of restoring PHA MCL biosynthesis in the N-methyl-NЈ-nitro-Nnitrosoguanidine mutant PhaG N -21 of P. putida, which was strongly impaired in PHA MCL synthesis from nonrelated carbon sources. The establishment of this pathway in non-Pseudomonas species has not been achieved yet. In order to further analyze this possibility, we generated independent Tn5 mutants of P. putida. For this, we constructed the suicide plasmid pMON5302, which enabled Tn5-mediated random insertion of a Gm r cassette into the P. putida chromosome. After transfer of plasmid pMON5302 into P. putida, cells were screened on MM containing gluconate as the sole carbon source. Five nonopaque mutants (B349/Tn5-1 to -5) were isolated that were strongly impaired in PHA MCL biosynthesis from nonrelated carbon sources but accumulated significantly higher levels of PHA MCL from decanoate as the carbon source (data not shown). Transfer of plasmid pBHR81, which carries the phaG Pp gene under the lac promoter's control, into these Tn5 mutants showed restoration of PHA MCL accumulation from nonrelated carbon sources comparable to the level of PHA MCL accumulation from decanoate as the carbon source (Fig. 4) . Analysis of PHA MCL composition by GC-mass spectrometry showed that the molar fraction of 3HD was decreased, whereas the molar fraction of 3-hydroxydodecanoate (3HDD) was increased in the Tn5 mutants when compared with that in wild-type P. putida (Fig. 5) . Functional expression of phaG Pp in these mutants again enhanced the molar fraction of 3HD and decreased the molar fraction of 3HDD of the accumulated PHA MCL .
Establishment of transacylase-mediated PHA MCL biosynthesis in recombinant E. coli. We recently reported the establishment of the transacylase-mediated PHA MCL biosynthesis pathway in the non-PHA accumulating P. fragi by functional expression of phaG Pp plus phaC1 Pa using plasmid pBHR86 (8) . These data clearly demonstrated that diversion of intermedi- ates from fatty acid ␤-oxidation is not required to establish the transacylase-mediated pathway. Therefore, we introduced plasmid pBHR86, which contains phaCl Pa and phaG Pp collinear to the lac promoter with phaG Pp still preceded by its native promoter, into E. coli JM109. Cells were cultivated either in LB medium or M9 medium containing gluconate as the sole carbon source. No PHA MCL accumulation was observed. To avoid transcriptional deficiency of phaG Pp in E. coli due to its native promoter, we constructed plasmid pBHR87, containing the phaG Pp gene without its native promoter. However, plasmid pBHR87 did not mediate PHA MCL biosynthesis in E. coli JM109. Since (R)-3-hydroxyacyl-ACP, an intermediate of fatty acid de novo biosynthesis and substrate for the transacylase PhaG, has to be available for PHA MCL biosynthesis from nonrelated carbon sources, we employed two E. coli fab mutants, which might contain higher levels of (R)-3-hydroxyacyl-ACP. The fabA mutant E. coli DC170 and the fabI mutant E. coli IP1111 were used to establish the transacylasemediated pathway. However, transfer of plasmids pBHR86 and pBHR87 into each of the mutants, respectively, alone did not mediate PHA MCL accumulation. Therefore, we used inhibitors of fatty acid de novo biosynthesis in order to generate an intermediate pool, which might favor provision of the substrate for the transacylase. We employed cerulenin, which specifically inhibits FabB (␤-ketoacyl-ACP synthase I) and FabF (␤-ketoacyl-ACP synthase II), which catalyze the condensation of malonyl-ACP with acyl-ACP (7). The application of the inhibitor cerulenin did not show any effect on PHA MCL synthesis from nonrelated carbon sources in recombinant E. coli S17-1. However, application of triclosan, which specifically inhibits the enoyl-ACP reductase (11), led to PHA MCL accumulation contributing to about 2 to 3% of cellular dry weight in recombinant E. coli harboring either pBHR86 or pBHR87, when grown on LB medium plus gluconate as the carbon source (Table 3) .
DISCUSSION
In this study, we evaluated the role of fatty acid de novo biosynthesis for PHA MCL synthesis and rhamnolipid production, particularly considering the role of the linking enzymes PhaG, transacylase, and Rh1G, ␤-ketoacyl reductase. Analysis of PHA MCL synthesis and rhamnolipid production in various isogenic fab mutants of P. aeruginosa, impaired in fatty acid de novo biosynthesis, strongly suggested that precursors for PHA MCL biosynthesis and rhamnolipid biosynthesis are provided via fatty acid de novo biosynthesis. This is consistent with the observation that the PHA MCL biosynthesis transacylase PhaG and the rhamnolipid biosynthesis ␤-ketoacyl reductase Rh1G use intermediates of fatty acid de novo biosynthesis as the substrate, which are converted by the respective enzyme to a direct precursor of PHA MCL or rhamnolipid biosynthesis, respectively (4, 28) . It is still not clear why the rhlG mutant ACP5 is strongly impaired in PHA MCL biosynthesis and why the phaG mutant KO2 showed a slightly decreased rhamnolipid production. Functional expression of phaG Pp in the fab mutants enhanced carbon flux towards PHA MCL biosynthesis, whereas rhamnolipid production was almost abolished, which indicated that PhaG catalyzes conversion of a molecule that plays a role in rhamnolipid biosynthesis. Interestingly, expression of phaG Pp in P. aeruginosa KO2 (phaG mutant) did not abolish rhamnolipid biosynthesis, suggesting that the original genomic phaG gene is required in addition to phaG Pp gene copies, provided by plasmid pBHR81, for efficient diversion of intermediates towards PHA biosynthesis. The finding that expression of rhlG Pa decreased PHA MCL accumulation in all mutants, except the ACP5 mutants, indicated that PHA MCL biosynthesis and rhamnolipid biosynthesis interfere with each other, presumably by competing for intermediates. Mutant ACP5 (rhlG) harboring plasmid pJC3 (rhlG Pa ) might not exhibit the same phenotype, because of the missing genomic rhlG Pa gene.
Five independent Tn5 mutants of P. putida which are deficient in PHA MCL accumulation from nonrelated carbon sources were all at least to some extent complemented by constitutive expression of phaG, which indicated that PhaG is the only key enzyme linking fatty acid de novo biosynthesis with PHA MCL biosynthesis. The compositional analysis of the PHA MCL accumulated by the Tn5 mutants suggested that PhaG contributed to PHA MCL biosynthesis by strong provision of 3-hydroxydecanoyl-CoA, presumably reflecting the substrate specificity of PhaG. Since the transacylase PhaG seems to be the only required enzyme for PHA MCL biosynthesis from nonrelated carbon sources, and since fatty acid de novo biosynthesis plays a crucial role in the provision of precursors for PHA MCL biosynthesis from nonrelated carbon sources, we employed fab mutants of E. coli as well as specific inhibitors of fatty acid de novo biosynthesis in order to establish the transacylase-mediated route in recombinant E. coli. However, only the application of triclosan, a specific inhibitor of the enoyl-ACP reductase FabI, enabled weak PHA MCL accumulation from nonrelated carbon sources in E. coli when phaG Pp and phaCl Pa were functionally expressed. Overall, this study indicates that carbon flux through the fatty acid de novo biosynthesis, i.e., the pool of intermediates, is crucial for PHA MCL biosynthesis as well as rhamnolipid production and that fatty acid de novo biosynthesis in pseudomonads is different from that in E. coli. a Recombinant E. coli was cultivated in LB medium containing 1.5% (wt/vol) gluconate, 1 mM isopropyl-␤-D-thiogalactopyranoside and kanamycin (50 g/ ml). After 24 h of cultivation at 37°C, triclosan was added to the medium at a final concentration of 0.1 g/ml, and cells were harvested after a further incubation of 24 h.
b Abbreviations: 3HB, 3-hydroxybutyrate; 3HDD, 3-hydroxydodecanoate.
